The Epoch Times
The Epoch Times
AD
The Epoch Times
Support Us
Australia News

Excess Mortality Levels 5 Percent Above Average in Australia, but Falling

Rates of excess mortality in Australia remain above what would normally be expected, a trend which began in 2021. However, 2023’s rate is half that of 2022.
0
FacebookXTruthGettrLinkedInTelegramEmail
Excess Mortality Levels 5 Percent Above Average in Australia, but Falling
Health workers conduct COVID-19 tests at the Bondi Beach testing clinic in Sydney, Australia, on Dec. 28, 2021. Jenny Evans/Getty Images
Rex Widerstrom
Rex Widerstrom
7/4/2024|Updated: 7/4/2024
0:00

The latest data from the Australian Bureau of Statistics (ABS) shows that excess mortality in Australia is still tracking significantly above normal levels, despite 2023 seeing a major decrease compared to the previous year.

Last year, there were 5.1 percent more deaths than would normally be expected for the period; the previous year, the figure was 11.7 percent.

Rex Widerstrom
Rex Widerstrom
Author
Rex Widerstrom is a New Zealand-based reporter with over 40 years of experience in media, including radio and print. He is currently a presenter for Hutt Radio.
Author’s Selected Articles

Stronger Support Needed so Chinese-Australians Can Freely Criticise Beijing: Academic

Nov 14, 2025
Stronger Support Needed so Chinese-Australians Can Freely Criticise Beijing: Academic

South Korea Could Get Nuclear Subs 10 Years Earlier Than Australia: Analysts

Nov 13, 2025
South Korea Could Get Nuclear Subs 10 Years Earlier Than Australia: Analysts

Flight Crew Error Caused 2 Near Misses in 2 Weeks at Melbourne Airport

Nov 11, 2025
Flight Crew Error Caused 2 Near Misses in 2 Weeks at Melbourne Airport

New Zealand to Spend $50 Million to Stem the Tide of Meth

Nov 10, 2025
New Zealand to Spend $50 Million to Stem the Tide of Meth
Related Topics
Australia
Australia COVID-19
Australian Bureau of Statistics
excess mortality
Add to My List
Save
The Epoch Times
Copyright © 2000 - 2025 The Epoch Times Association Inc. All Rights Reserved.